LPCAT3 and non-small cell lung carcinoma: Yet, we saw that C3F was significantly elevated in the serum from patients with NSCLC (median = 4.02 nM, range: 2.54–20.2 nM) compared to serum from the healthy individuals (median = 2.54 nM, range: 2.54–6.04 nM) (p < 0.0001) (Figure 2a).